The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

Share Price Information for Centaur (CAU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.00
Bid: 51.00
Ask: 53.00
Change: 0.50 (0.97%)
Spread: 2.00 (3.922%)
Open: 51.50
High: 52.00
Low: 51.50
Prev. Close: 51.50
CAU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Swag Mukerji succeeds Andria Vidler as CEO

4 Sep 2019 07:00

RNS Number : 1148L
Centaur Media PLC
04 September 2019
 

4 September 2019

 

Centaur Media Plc

 

("Centaur" or "the Group")

 

Swag Mukerji succeeds Andria Vidler as CEO of Centaur

 

Centaur Media Plc, an international provider of business information and specialist consultancy, today announces that Andria Vidler has decided to step down as chief executive officer of the Company in order to explore new opportunities. Andria is succeeded by Swag Mukerji, chief financial officer since 2016. Andria will continue as a director to work with Swag during September to ensure a smooth transition before stepping down on 30th September 2019.

 

During her six years at Centaur, Andria spearheaded a transformation that has seen the business evolve from a traditional publishing group into an international provider of business information and specialist consultancy. Under Andria's guidance, leading brands like Marketing Week, Econsultancy and The Lawyer benefitted from significant innovation and digital product development, and Centaur expanded its marketing capabilities with the acquisitions of MarketMakers and Oystercatchers. The marketing division has now been reorganised and named Xeim to offer clients this broader range of products and services. Following the conclusion of a strategic review in October 2018, Andria oversaw a disposal programme which has raised more than £20 million in cash, simplified the Group's portfolio and increased focus on Centaur's core brands.

 

Swag has extensive experience as CEO and CFO in both listed and private equity-backed companies, including Biocompatibles International plc, the listed healthcare company. His other roles included as CEO of Virgin Drinks and SafetyKleen UK; as group executive director of First Assist; and as COO and CFO of Priory Healthcare, reporting to the Chairman.

 

Centaur's nomination committee has initiated the search for a new CFO. Until an appointment is made, Swag will retain overall responsibility for finance.

 

Colin Jones, chairman, commented:

 

"Andria has been a driving force in the transformation of Centaur and I, and the rest of the board, would like to thank her for the valuable contribution she has made to the Company's development. Today's Centaur is a stronger and more resilient business compared to the advertising-dependent publishing group of six years ago. I wish Andria all the best for the future.

"The board is pleased that Swag has agreed to succeed Andria as CEO. Swag's important role in Centaur's transformation and comprehensive understanding of the Company will be of great benefit in ensuring continuity and delivering value to shareholders."

 

Andria Vidler said:

 

"I am incredibly proud of what has been achieved during my time as CEO of Centaur. The business has undergone a radical transformation and is unrecognisable from the B2B publisher that I joined nearly six years ago. Our strategy has delivered a total shareholder return of more than 30% over the past three years and, with the recent divestments now completed, I feel it is the right time for me to step down and hand the reins to Swag, who I am confident will maintain Centaur's ongoing progress.

 

"I would like to take this opportunity to thank all Centaurions for their dedication, good humour and hard work and wish them, and the business, all the best for the future."

 

Swag Mukerji said:

 

"It has been a pleasure to work with Andria over the past three years and I am delighted with the progress that we made in improving Centaur. I will continue to drive efforts to grow our core businesses while ensuring shareholders benefit from the simplification of the portfolio brought about by our recent divestments, including the opportunity to increase efficiencies to improve our margins further. I wish Andria every success with her future plans."

 

 

Enquiries

 

Centaur Media Plc

Colin Jones, Chairman

020 7970 4000

Andria Vidler, Chief Executive Officer

Swag Mukerji, Chief Financial Officer

Teneo

Paul Durman/Rebecca Hislaire

020 7420 3144

 

Note to editors

 

Centaur

Centaur is an international provider of business information and specialist consultancy that inspires and enables people to excel at what they do, raising the standard for insight, interaction and impact.

 

Leading brands include: Econsultancy, Marketing Week, Festival of Marketing, MarketMakers, Creative Review, Influencer Intelligence, Fashion & Beauty Monitor, Oystercatchers and The Lawyer.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAXNDESSNEFF
Date   Source Headline
17th Jul 20233:43 pmRNSDirector/PDMR Shareholding
21st Jun 20233:28 pmRNSDirector/PDMR Shareholding
1st Jun 202311:18 amRNSDirector Declaration
31st May 20234:35 pmRNSDirector Declaration
18th May 202311:44 amRNSDirector/PDMR Shareholding
10th May 20233:33 pmRNSResult of AGM
18th Apr 202311:47 amRNSDirector/PDMR Shareholding
12th Apr 20232:41 pmRNSDirector/PDMR Shareholding
4th Apr 20231:48 pmRNSAnnual Financial Report
21st Mar 20239:51 amRNSHolding(s) in Company
20th Mar 20233:33 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
20th Feb 20239:30 amRNSDirector/PDMR Shareholding
31st Jan 20239:01 amRNSHolding(s) in Company
23rd Jan 20239:25 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update & Declaration of a Special Dividend
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20222:19 pmRNSDirector/PDMR Shareholding
22nd Nov 20221:52 pmRNSDirector/PDMR Shareholding
16th Nov 20223:57 pmRNSDirector/PDMR Shareholding
24th Oct 20229:37 amRNSDirector/PDMR Shareholding
23rd Sep 202211:24 amRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 20225:13 pmRNSDirector/PDMR Shareholding
25th Jul 20229:50 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSInterim Results
5th Jul 202210:30 amRNSDirector/PDMR Shareholding
23rd May 202210:33 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSNon-Executive Director Appointment
12th May 202211:08 amRNSDirector/PDMR Shareholding
11th May 20223:09 pmRNSResult of AGM
21st Apr 202211:27 amRNSDirector/PDMR Shareholding
1st Apr 202211:54 amRNSAnnual Financial Report
25th Mar 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20223:24 pmRNSDirector/PDMR Shareholding
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
18th Mar 20229:31 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSPreliminary results
22nd Feb 20223:03 pmRNSDirector/PDMR Shareholding
20th Jan 202210:59 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSTrading Update
21st Dec 20214:31 pmRNSDirector/PDMR Shareholding
22nd Nov 202111:24 amRNSDirector/PDMR Shareholding
12th Nov 20219:54 amRNSHolding(s) in Company
12th Nov 20219:52 amRNSHolding(s) in Company
10th Nov 202110:11 amRNSNotification of major holdings
1st Nov 20214:18 pmRNSHolding(s) in Company
1st Nov 20211:46 pmRNSHolding(s) in Company
1st Nov 202110:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.